Evidence map›Paper›PMID 40775483›Full record

SynthesisInternational journal of clinical pharmacy2025

The effect of pharmacist intervention on medication adherence measured with proportion of days covered: a systematic review and meta-analysis.

Lei Wang, Yuyanzi Zhang, Qiran Wei, Xiao Liang, Jiting Zhou, Aixia Ma, Luying Wang

Abstract readSystematic ReviewMeta-Analysis
PubMed Publisher
In one paragraph

Synthesis in International journal of clinical pharmacy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lei WangSchool of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China.
Yuyanzi ZhangSchool of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China.
Qiran WeiSchool of Pharmacy, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China.
Xiao LiangDepartment of Pharmacy, Qilu Hospital of Shandong University, Jinan, China.
Jiting ZhouSchool of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China.
Aixia MaSchool of International Pharmaceutical Business, China Pharmaceutical University, #639 Longmian Avenue, Jiangning District, Nanjing, 211198, China.
Luying WangSchool of International Pharmaceutical Business, China Pharmaceutical University, #639 Longmian Avenue, Jiangning District, Nanjing, 211198, China. luying_w@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPharmacist-led interventions improve medication outcomes, but existing evidence on adherence remains limited by heterogeneous tools and qualitative outcomes. The proportion of days covered (PDC) offers a quantifiable measure of adherence, with recommended threshold (PDC ≥ 80%) supporting evidence-based optimization of pharmacy services in chronic care management. However, studies using PDC to evaluate pharmacist interventions versus usual care show heterogeneity.

aimThis study aimed to systematically review and meta-analyze the effect of pharmacist-led interventions versus usual care using standardized PDC-based outcomes, and synthesize quantifiable evidence for pharmacy practice.

methodFive databases were searched from inception to March 2024. Eligible studies included randomized controlled trials (RCTs) or non-randomized studies evaluating pharmacist-led interventions versus usual care with adherence measured by PDC. Two reviewers independently screened studies and extracted data. RCTs were assessed using Cochrane risk of bias 2.0 and non-randomized studies with the Newcastle-Ottawa Scale. Meta-analyses were conducted using random-effects models (I

resultsTwenty-nine studies were included in the analysis. Quality appraisal identified 54.5% of non-randomized studies as high quality, and the majority of RCTs were rated as low risk or some concerns. Pharmacist-led interventions significantly enhanced adherence versus usual care, with a pooled MD of 0.08 (95% CI 0.04-0.12) for mean PDC and an RR of 1.09 (95% CI 1.06-1.13) for adherence rate. Greater effects were observed for lipid-lowering (MD = 0.08, 0.04-0.11) and hypotensive medications (MD = 0.06, 0.03-0.10) than for antidiabetics (MD = 0.02, 0.01-0.03), for 6-month (MD = 0.12, 0.07-0.17) versus 12-month interventions (MD = 0.03, 0.01-0.06), and for telephone-based delivery (RR = 1.16, 1.06-1.28) versus multifaceted counterparts (RR = 1.12, 1.01-1.25). High heterogeneity was observed across pooled analyses. Sensitivity analyses confirmed the robustness of results.

conclusionPharmacist-led interventions enhance medication adherence in mean PDC and adherence rate. These consistent effects across different durations and delivery methods show their adaptability and scalability in clinical settings, highlighting their value in real-world pharmacy practice.

Indexed as

Medication AdherencePharmaceutical ServicesPharmacistsProfessional RoleHumansRandomized Controlled Trials as TopicMedication adherenceMeta-analysisPharmacistsProportions of days coveredSystematic review

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.